Alzheimer's Disease Trial, Not Yet Recruiting
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- The trial is open to two types of participants: people living with a chronic condition or cognitive impairment (and their caregivers).
- A score of 10 or higher on a standard sleep problem questionnaire (called the Insomnia Severity Index) is required.
- Participants must have trouble falling asleep, staying asleep, or waking up too early, at least three nights per week.
- Sleep problems must have been ongoing for at least three months.
- Participants must experience daytime problems caused by poor sleep, such as tiredness or mood changes.
- Participants must be living in the community (not in a hospital or care facility).
- The person with the condition and their caregiver must be living together.
- Access to the internet is required.
- Participants must not have had surgery in the past 4 weeks.
- Caregivers must have been regularly helping the person they care for with at least one basic daily living activity (such as bathing or dressing) or one household or daily management task for the past 6 months.
- For the person with cognitive impairment: a reported or diagnosed cognitive impairment is required, and the person must be able to follow simple instructions.
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- People with a diagnosis of psychosis, major depressive disorder, or bipolar disorder that is currently not being treated.
- People who have had a substance or alcohol dependency, or active thoughts of suicide, in the past year.
- People who currently have narcolepsy or restless leg syndrome.
- People who do shift work.
- People who plan to travel across time zones during the data collection periods.
- People with a hearing or visual impairment.
- Caregivers who have dementia or cognitive impairment.
- People who are not yet adults.
- People who are pregnant.
- People who are in prison.
- People who are not able to clearly understand English.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
If you need support right now
This page includes language about suicide and self-harm, because that is how the trial's eligibility criteria are written. If reading it has been hard, you do not have to keep going. The services below are free, confidential, and answered by people trained for exactly this.
If you or someone else is in immediate danger, call 000.
- Lifeline — 24/7 crisis support: 13 11 14
- Suicide Call Back Service — 24/7 counselling: 1300 659 467
- 13YARN — 24/7, for Aboriginal and Torres Strait Islander people: 13 92 76
- Beyond Blue — 24/7 mental health support: 1300 22 4636
- Emergency: 000
Outside Australia? The numbers above are Australian and will not work from overseas. Find a Helpline is a free directory of crisis lines in over 130 countries, run by ThroughLine with the International Association for Suicide Prevention. If you are in immediate danger, call your local emergency number.
Voxsanity is not a crisis service, and nothing on this page is medical advice. More Australian services are listed on our support lines page.
Contact this trial
Principal Investigator: Glenna Brewster, PhD, RN, Emory University
Phone: (404) 712-9164
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Primary endpoints
Change in insomnia severity
Can't join this trial?
Data last synced from ClinicalTrials.gov: 7 August 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.